B-Disease	0	8	Cataract
O	9	16	surgery
O	17	19	is
O	20	30	associated
O	31	35	with
O	36	37	a
O	38	44	higher
O	45	49	rate
O	50	52	of
O	53	65	photodynamic
O	66	73	therapy
O	74	77	for
B-Disease	78	81	age
I-Disease	81	82	-
I-Disease	82	89	related
I-Disease	90	97	macular
I-Disease	98	110	degeneration
O	110	111	.

O	113	115	To
O	116	127	investigate
O	128	131	the
O	132	143	association
O	144	151	between
B-Disease	152	160	cataract
O	161	168	surgery
O	169	172	and
O	173	176	the
O	177	181	rate
O	182	184	of
O	185	197	photodynamic
O	198	205	therapy
O	206	207	(
O	207	210	PDT
O	210	211	)
O	212	215	for
B-Disease	216	219	age
I-Disease	219	220	-
I-Disease	220	227	related
I-Disease	228	235	macular
I-Disease	236	248	degeneration
O	249	250	(
B-Disease	250	253	AMD
O	253	254	)
O	254	255	.

O	256	269	Observational
O	270	280	population
O	280	281	-
O	281	286	based
O	287	300	retrospective
O	301	305	case
O	305	306	-
O	306	313	control
O	314	319	study
O	319	320	.

O	321	324	All
O	325	332	members
O	333	335	in
O	336	337	a
O	338	346	district
O	347	349	of
O	350	353	the
O	354	361	largest
O	362	368	health
O	369	380	maintenance
O	381	393	organization
O	394	395	(
O	395	398	HMO
O	398	399	)
O	400	402	in
B-Characteristic	403	409	Israel
I-Characteristic	411	412	>
I-Characteristic	414	416	50
I-Characteristic	417	422	years
I-Characteristic	423	426	old
O	427	429	on
O	430	437	January
O	438	439	1
O	439	440	,
O	441	445	2001
O	445	446	,
O	447	450	who
O	451	454	did
O	455	458	not
O	459	468	terminate
O	469	474	their
O	475	485	membership
O	486	493	through
O	494	497	May
O	498	500	31
O	500	501	,
O	502	506	2005
O	507	508	(
O	508	511	139
O	512	515	894
O	516	523	members
O	523	524	)
O	524	525	.

O	526	529	All
O	530	533	PDT
O	534	544	procedures
O	545	548	for
B-Disease	549	552	AMD
O	553	562	performed
O	563	565	in
O	566	569	the
O	570	575	study
O	576	586	population
O	587	594	between
O	595	602	January
O	603	604	1
O	604	605	,
O	606	610	2001
O	611	614	and
O	615	618	May
O	619	621	31
O	621	622	,
O	623	627	2005
O	628	629	(
O	629	632	283
O	633	641	patients
O	641	642	)
O	643	646	and
O	647	650	all
B-Disease	651	659	cataract
O	660	669	surgeries
O	670	679	performed
O	680	687	between
O	688	695	January
O	696	697	1
O	697	698	,
O	699	703	2001
O	704	707	and
O	708	716	December
O	717	719	31
O	719	720	,
O	721	725	2003
O	726	727	(
O	727	731	5913
O	732	740	patients
O	740	741	)
O	742	746	were
O	747	757	documented
O	757	758	.

O	759	761	We
O	762	771	extracted
O	772	780	clinical
O	781	792	information
O	793	797	from
O	798	801	the
O	802	809	chronic
O	810	817	disease
O	818	826	registry
O	827	829	of
O	830	833	the
O	834	837	HMO
O	838	840	as
O	841	845	well
O	846	848	as
O	849	860	demographic
O	861	864	and
O	865	878	socioeconomic
O	879	890	information
O	890	891	.

O	892	895	For
O	896	900	each
O	901	908	patient
O	909	913	that
O	914	923	underwent
B-Disease	924	932	cataract
O	933	940	surgery
O	940	941	,
O	942	943	5
O	944	947	HMO
O	948	955	members
O	956	963	matched
O	964	966	in
B-Characteristic	967	970	age
O	970	971	,
B-Characteristic	972	978	gender
O	978	979	,
B-Disease	980	987	chronic
I-Disease	988	996	diseases
O	997	998	(
B-Disease	998	1006	systemic
I-Disease	1007	1019	hypertension
O	1019	1020	,
B-Disease	1021	1029	diabetes
O	1029	1030	,
B-Disease	1031	1043	hyperlipemia
O	1043	1044	,
O	1045	1048	and
B-Disease	1049	1057	ischemic
I-Disease	1058	1063	heart
I-Disease	1064	1071	disease
O	1071	1072	)
O	1072	1073	,
B-Characteristic	1074	1079	place
I-Characteristic	1080	1082	of
I-Characteristic	1083	1092	residence
O	1092	1093	,
B-Characteristic	1094	1101	country
I-Characteristic	1102	1104	of
I-Characteristic	1105	1110	birth
O	1111	1114	and
B-Characteristic	1115	1128	socioeconomic
I-Characteristic	1129	1135	status
O	1135	1136	,
O	1137	1140	who
O	1141	1144	did
O	1145	1148	not
O	1149	1156	undergo
B-Disease	1157	1165	cataract
O	1166	1173	surgery
O	1173	1174	,
O	1175	1179	were
O	1180	1188	randomly
O	1189	1195	chosen
O	1196	1198	as
O	1199	1207	controls
O	1208	1209	(
O	1209	1210	n
O	1211	1212	=
O	1213	1215	29
O	1216	1219	565
O	1219	1220	)
O	1220	1221	.

O	1222	1225	The
O	1226	1230	rate
O	1231	1234	for
O	1235	1245	undergoing
O	1246	1249	PDT
O	1250	1252	at
O	1253	1262	different
O	1263	1267	time
O	1268	1275	periods
O	1276	1281	after
B-Disease	1282	1290	cataract
O	1291	1298	surgery
O	1298	1299	.

O	1300	1305	Fifty
O	1306	1307	(
O	1307	1308	0
O	1308	1309	.
O	1309	1311	85
O	1311	1312	%
O	1312	1313	)
B-Disease	1314	1322	cataract
O	1323	1331	patients
O	1332	1335	and
O	1336	1338	94
O	1339	1346	control
O	1347	1352	cases
O	1353	1354	(
O	1354	1355	0
O	1355	1356	.
O	1356	1358	32
O	1358	1359	%
O	1359	1360	)
O	1361	1370	underwent
O	1371	1374	PDT
O	1375	1380	after
B-Disease	1381	1389	cataract
O	1390	1397	surgery
O	1398	1399	(
O	1399	1400	P
O	1401	1402	<
O	1403	1404	0
O	1404	1405	.
O	1405	1409	0001
O	1409	1410	,
O	1411	1414	chi
O	1414	1415	-
O	1415	1421	square
O	1422	1426	test
O	1426	1427	)
O	1427	1428	.

O	1429	1430	A
O	1431	1442	significant
O	1443	1447	rise
O	1448	1450	in
O	1451	1454	PDT
O	1455	1459	rate
O	1460	1463	was
O	1464	1471	noticed
O	1472	1474	in
B-Disease	1475	1483	cataract
O	1484	1492	patients
O	1493	1501	compared
O	1502	1504	to
O	1505	1513	controls
O	1514	1520	during
O	1521	1524	the
O	1525	1530	first
O	1531	1532	6
O	1533	1539	months
O	1540	1545	after
O	1546	1553	surgery
O	1554	1555	(
O	1555	1556	P
O	1557	1558	=
O	1559	1560	0
O	1560	1561	.
O	1561	1564	004
O	1564	1565	,
O	1566	1569	chi
O	1569	1570	-
O	1570	1576	square
O	1577	1581	test
O	1581	1582	)
O	1582	1583	.

O	1584	1591	Between
O	1592	1593	6
O	1594	1597	and
O	1598	1600	12
O	1601	1607	months
O	1608	1623	postoperatively
O	1623	1624	,
O	1625	1628	the
O	1629	1632	PDT
O	1633	1638	rates
O	1639	1643	were
O	1644	1651	similar
O	1652	1654	in
O	1655	1659	both
O	1660	1666	groups
O	1666	1667	.

O	1668	1675	However
O	1675	1676	,
O	1677	1678	a
O	1679	1683	more
O	1684	1695	significant
O	1696	1700	rise
O	1701	1703	in
O	1704	1707	PDT
O	1708	1713	rates
O	1714	1722	occurred
O	1723	1730	between
O	1731	1732	1
O	1733	1736	and
O	1737	1738	1
O	1738	1739	.
O	1739	1740	5
O	1741	1746	years
O	1747	1752	after
O	1753	1760	surgery
O	1761	1762	(
O	1762	1763	P
O	1764	1765	<
O	1766	1767	0
O	1767	1768	.
O	1768	1772	0001
O	1772	1773	,
O	1774	1777	chi
O	1777	1778	-
O	1778	1784	square
O	1785	1789	test
O	1789	1790	)
O	1790	1791	.

O	1792	1795	The
O	1796	1802	Kaplan
O	1802	1803	-
O	1803	1808	Meier
O	1809	1812	PDT
O	1812	1813	-
O	1813	1817	free
O	1818	1826	survival
O	1827	1832	curve
O	1833	1835	of
B-Disease	1836	1844	cataract
O	1845	1853	patients
O	1854	1857	was
O	1858	1871	significantly
O	1872	1877	worse
O	1878	1882	than
O	1883	1887	that
O	1888	1890	of
O	1891	1894	the
O	1895	1903	controls
O	1904	1905	(
O	1905	1906	P
O	1907	1908	<
O	1909	1910	0
O	1910	1911	.
O	1911	1915	0001
O	1915	1916	,
O	1917	1920	chi
O	1920	1921	-
O	1921	1927	square
O	1928	1932	test
O	1932	1933	;
O	1934	1935	P
O	1936	1937	=
O	1938	1940	33
O	1940	1941	.
O	1941	1942	7
O	1942	1943	,
O	1944	1947	log
O	1947	1948	-
O	1948	1952	rank
O	1953	1957	test
O	1957	1958	)
O	1958	1959	.

O	1960	1963	The
O	1964	1970	hazard
O	1971	1976	ratio
O	1977	1980	for
B-Disease	1981	1989	cataract
O	1990	1998	patients
O	1999	2007	compared
O	2008	2010	to
O	2011	2019	controls
O	2020	2022	to
O	2023	2030	undergo
O	2031	2034	PDT
O	2035	2040	after
O	2041	2048	surgery
O	2049	2052	was
O	2053	2054	2
O	2054	2055	.
O	2055	2056	7
O	2057	2058	(
O	2058	2068	confidence
O	2069	2077	interval
O	2078	2079	=
O	2080	2081	2
O	2081	2082	.
O	2082	2083	4
O	2083	2084	-
O	2084	2085	5
O	2085	2086	.
O	2086	2087	7
O	2087	2088	)
O	2088	2089	.

O	2090	2093	The
O	2094	2098	most
O	2099	2110	significant
O	2111	2118	factors
O	2119	2121	to
O	2122	2128	reduce
O	2129	2132	the
O	2133	2137	time
O	2138	2140	to
O	2141	2144	PDT
O	2145	2149	were
B-Characteristic	2150	2158	advanced
I-Characteristic	2159	2162	age
O	2163	2171	followed
O	2172	2174	by
O	2175	2181	having
O	2182	2185	had
B-Disease	2186	2194	cataract
O	2195	2202	surgery
O	2202	2203	,
B-Characteristic	2204	2209	place
I-Characteristic	2210	2212	of
I-Characteristic	2213	2218	birth
O	2218	2219	,
B-Characteristic	2220	2233	socioeconomic
I-Characteristic	2234	2240	status
O	2240	2241	,
O	2242	2245	and
B-Symptom	2246	2260	hyperlipidemia
O	2261	2262	(
O	2262	2265	Cox
O	2266	2278	proportional
O	2279	2286	hazards
O	2287	2295	survival
O	2296	2306	regression
O	2306	2307	)
O	2307	2308	.

O	2309	2311	We
O	2312	2322	identified
O	2323	2325	an
O	2326	2335	increased
O	2336	2340	rate
O	2341	2343	of
O	2344	2347	PDT
O	2347	2348	,
O	2349	2359	presumably
O	2360	2363	for
B-Disease	2364	2373	subfoveal
I-Disease	2374	2377	AMD
O	2377	2378	,
O	2379	2380	1
O	2381	2383	to
O	2384	2385	1
O	2385	2386	.
O	2386	2387	5
O	2388	2393	years
O	2394	2399	after
B-Disease	2400	2408	cataract
O	2409	2416	surgery
O	2416	2417	.
